PubMed laboratory research record [PMID: 11422928] PubMed record related to this compound for laboratory literature review
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
I am seeking therapy for that
Not all of these options meet the necessary safety and quality standards
Practical implementation considerations include: Post-meal activity : Even light walking (10-15 minutes) after meals may improve postprandial glucose levels Reducing sedentary time : Breaking up prolonged sitting with brief activity every 30 minutes Consistency over intensity : Regular moderate activity provides greater metabolic benefit than sporadic vigorous exercise Individualization : Exercise prescriptions should account for baseline fitness, comorbidities, and personal preferences to optimize adherence Special precautions are needed for those with diabetes complications, including proper footwear with neuropathy, avoiding high-impact or head-down exercises with retinopathy, and appropriate cardiovascular assessment before beginning vigorous exercise